AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer

Caliway to present preclinical data on CBL-514 in combination with GLP-1R therapy at ADA 2026 Scientific Sessions

Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development

Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal

NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development

Alltrna granted approval for first-in-human clinical trial of AP003

Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share

Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management

AstraZeneca reports positive phase III results for efzimfotase alfa in hypophosphatasia

Galapagos and Gilead expand collaboration to advance T cell engager programme

Sanofi secures EU approval for Rezurock in chronic graft-versus-host disease

Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104

Hengrui Pharma and Braveheart Bio report positive Phase 2 results for HRS/BHB-1893 in oHCM

Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME

Fusion Antibodies signs GBP250,000 IP transfer deal with Finn Therapeutics